Baird Small/Mid Cap Growth Fund Institutional (BSGIX)
16.02
-0.14
(-0.87%)
USD |
Mar 04 2025
Returns Chart
Key Stats
Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
---|---|---|---|
-- | -- | -- | -- |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
-- | -- | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The Fund seeks to provide long-term growth of capital. The Fund normally invests at least 80% of its net assets, plus any borrowings, in the equity securities of US and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts that are traded on major US exchanges. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US Sm&Mid Cap |
Peer Group | Small-Cap Growth Funds |
Global Macro | Equity North America |
US Macro | Small-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Small-Cap Funds |
Fund Owner Firm Name | Baird |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 05, 2025.
Asset Allocation
As of December 31, 2024.
Type | % Net |
---|---|
Cash | 1.39% |
Stock | 97.35% |
Bond | 1.26% |
Convertible | 0.00% |
Preferred | 0.00% |
Other | 0.00% |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
The Descartes Systems Group Inc | 2.86% | 157.74 | -1.22% |
Insulet Corp | 2.77% | 269.70 | -1.08% |
Tarsus Pharmaceuticals Inc | 2.72% | 44.45 | 4.05% |
First American Government Obligations Fd U | 2.63% | 1.00 | 0.00% |
Kinsale Capital Group Inc | 2.53% | 433.14 | 0.59% |
Neurocrine Biosciences Inc | 2.50% | 113.11 | -1.20% |
AAON Inc | 2.47% | 75.29 | 2.41% |
Lennox International Inc | 2.46% | 572.97 | -2.39% |
Dutch Bros Inc | 2.43% | 72.36 | -5.21% |
Boot Barn Holdings Inc | 2.35% | 111.82 | -2.66% |
Fees & Availability
Fees | |
Actual 12B-1 Fee | -- |
Actual Management Fee | 0.68% |
Administration Fee | -- |
Maximum Front Load | -- |
Maximum Deferred Load | -- |
Maximum Redemption Fee | -- |
General Availability | |
Available for Insurance Product | -- |
Available for RRSP | -- |
Purchase Details | |
Open to New Investors |
|
Minimum Initial Investment | 10000.00 None |
Minimum Subsequent Investment | 0.00 None |
Basic Info
Investment Strategy | |
The Fund seeks to provide long-term growth of capital. The Fund normally invests at least 80% of its net assets, plus any borrowings, in the equity securities of US and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts that are traded on major US exchanges. |
General | |
Security Type | Mutual Fund |
Broad Asset Class | US Equity |
Broad Category | Equity |
Global Peer Group | Equity US Sm&Mid Cap |
Peer Group | Small-Cap Growth Funds |
Global Macro | Equity North America |
US Macro | Small-Cap Funds |
YCharts Categorization | -- |
YCharts Benchmark | -- |
Prospectus Objective | Small-Cap Funds |
Fund Owner Firm Name | Baird |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Fundamentals
General | |
Distribution Yield | -- |
Dividend Yield TTM | -- |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Stock | |
Weighted Average PE Ratio | -- |
Weighted Average Price to Sales Ratio | -- |
Weighted Average Price to Book Ratio | -- |
Weighted Median ROE | -- |
Weighted Median ROA | -- |
ROI (TTM) | -- |
Return on Investment (TTM) | -- |
Earning Yield | -- |
LT Debt / Shareholders Equity | -- |
Growth Metrics
EPS Growth (1Y) | 22.33% |
EPS Growth (3Y) | 29.13% |
EPS Growth (5Y) | 25.87% |
Sales Growth (1Y) | 15.02% |
Sales Growth (3Y) | 26.41% |
Sales Growth (5Y) | 18.97% |
Sales per Share Growth (1Y) | 13.38% |
Sales per Share Growth (3Y) | 25.81% |
Operating Cash Flow - Growth Ratge (3Y) | 29.50% |
As of December 31, 2024
Fund Details
Key Dates | |
Inception Date | 10/31/2018 |
Last Annual Report Date | 12/31/2023 |
Last Prospectus Date | 5/1/2024 |
Share Classes | |
BSGSX | Inv |
Attributes | |
Index Fund | -- |
Inverse Fund | -- |
Leveraged Fund | -- |
Fund of Funds | No |
Currency Hedged Fund | -- |
Synthetic Replication Fund | No |
Top Portfolio Holders
Name | % Weight |
---|---|
Portfolio A | 5.00% |
Portfolio B | 3.50% |
Portfolio C | 2.25% |
Excel Add-In Codes
Name: =YCI("M:BSGIX", "name") |
Broad Asset Class: =YCI("M:BSGIX", "broad_asset_class") |
Broad Category: =YCI("M:BSGIX", "broad_category_group") |
Prospectus Objective: =YCI("M:BSGIX", "prospectus_objective") |
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |